Correlation Between ContraFect Corp and Neximmune
Can any of the company-specific risk be diversified away by investing in both ContraFect Corp and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ContraFect Corp and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ContraFect Corp and Neximmune, you can compare the effects of market volatilities on ContraFect Corp and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ContraFect Corp with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of ContraFect Corp and Neximmune.
Diversification Opportunities for ContraFect Corp and Neximmune
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ContraFect and Neximmune is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding ContraFect Corp and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and ContraFect Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ContraFect Corp are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of ContraFect Corp i.e., ContraFect Corp and Neximmune go up and down completely randomly.
Pair Corralation between ContraFect Corp and Neximmune
If you would invest 118.00 in ContraFect Corp on October 12, 2024 and sell it today you would earn a total of 0.00 from holding ContraFect Corp or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.54% |
Values | Daily Returns |
ContraFect Corp vs. Neximmune
Performance |
Timeline |
ContraFect Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ContraFect Corp and Neximmune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ContraFect Corp and Neximmune
The main advantage of trading using opposite ContraFect Corp and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ContraFect Corp position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.ContraFect Corp vs. Palisade Bio | ContraFect Corp vs. Allarity Therapeutics | ContraFect Corp vs. Cns Pharmaceuticals | ContraFect Corp vs. Windtree Therapeutics |
Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |